Skip to main content

Table 1 – Characteristics of the study populationa

From: Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural India

 

Overall (n = 62,194)

Male (n = 29,097)

Female (n = 33,097)

p-values

Age (years), mean (95% CI)

54·0 (53·7–54·3)

54·7 (54·4–55·1)

53·3 (53·0–53·6)

< 0·001

Female, % (95% CI)

53·2 (52·5–53·9)

   

Currently smoking, % (95% CI)

21·9 (20·6–23·2)

41·0 (38·5–43·4)

5·1 (4·4–5·8)

< 0·001

Currently chewing tobacco, % (95% CI)

1·5 (1·2–1·8)

3·1 (2·4–3·8)

0·1 (0·0–0·1)

< 0·001

Established CVD, % (95% CI)

4·0 (3·7–4·3)

5·0 (4·6–5·3)

3·2 (2·8–3·6)

< 0·001

Myocardial infarction/angina, % (95% CI)

2·3 (2·0–2·6)

2·7 (2·4–3·0)

2·0 (1·7–2·3)

< 0·001

Stroke, % (95% CI)

1·8 (1·6–1·9)

2·3 (2·1–2·6)

1·2 (1·0–1·5)

< 0·001

Peripheral vascular diseases, % (95% CI)

0·1 (0·1–0·2)

0·2 (0·1–0·3)

0·1 (0·0–0·1)

< 0·001

Self-reported diabetes, % (95% CI)

11·6 (10·6–12·6)

11·3 (10·2–12·3)

11·8 (10·8–12·9)

0·143

All diabetes, % (95% CI)

18·0 (16·8–19·2)

17·8 (16·6–18·9)

18·3 (16·9–19·6)

0·250

SBP (mmHg), mean (95% CI)

126·3 (125·2–127·3)

124·2 (123·4–125·1)

128·1 (126·8–129·4)

< 0·001

DBP (mmHg), mean (95% CI)

79·8 (79·2–80·4)

79·4 (78·8–79·9)

80·3 (79·6–80·9)

< 0·001

BP lowering treatment, % (95% CI)

19·6 (18·4–20·9)

16·1 (15·1–17·2)

22·7 (21·2–24·2)

< 0·001

10-year adjusted cardiovascular risk, % (95% CI)b

I

<  10% risk

63·9 (62·5–65·2)

63·3 (61·8–64·8)

64·4 (62·6–66·1)

0·168

II

10–20% risk

13·0 (12·5–13·5)

13·9 (13·0–14·7)

12·2 (11·7–12·6)

< 0·001

III

20–30% risk

5·3 (4·9–5·6)

5·9 (5·4–6·4)

4·8 (4·5–5·0)

< 0·001

IV

30–40% risk

1·2 (1·1–1·3)

1·8 (1·6–2·1)

0·6 (0·5–0·7)

< 0·001

V

> 40% risk

0·8 (0·8–0·9)

0·6 (0·5–0·7)

1·0 (0·9–1·2)

< 0·001

VI

Established CVD

4·0 (3·7–4·4)

5·0 (4·6–5·3)

3·2 (2·8–3·6)

< 0·001

VII

BP ≥160/100 mmHg

11·8 (11·1–12·5)

9·5 (8·9–10·1)

13·8 (12·9–14·8)

< 0·001

10-year adjusted cardiovascular risk groups, % (95% CI)b

 Low risk (I + II)

76·8 (75·7–78·0)

77·2 (76·1–78·4)

76·5 (75·1–78·0)

0·251

 Intermediate risk (III)

5·3 (4·9–5·6)

5·9 (5·4–6·4)

4·8 (4·5–5·1)

< 0·001

 High risk (IV + V + VI + VII)

17·9 (16·9–18·8)

16·9 (16·1–17·7)

18·7 (17·4–20·0)

0.001

  1. aWeighted estimates bAfter estimation of pre-treatment BP for those on BP lowering treatment
  2. CVD cardiovascular disease, SBP systolic blood pressure, DBP diastolic blood pressure, BP blood pressure
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us